NCT03931057View on ClinicalTrials.gov

The Use of ADV6209 for Premedication in Pediatric Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

September 17, 2021

Study Completion Date

September 17, 2021

Conditions
Preanesthetic Medication
Interventions
DRUG

ADV6209 (=gamma-cyclodextrin-Midazolam)

30 min. before anesthesia children have to swallow the anxiolytic drug (ADV6209)

DRUG

Midazolam

30 min. before anesthesia children have to swallow the anxiolytic drug Midazolam

Trial Locations (1)

1090

Medical University of Vienna, Dept. of Anesthesia, Intensive Care Medicine and Pain Medicine, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03931057 - The Use of ADV6209 for Premedication in Pediatric Anesthesia | Biotech Hunter | Biotech Hunter